Most independent pharmacy owners have heard of specialty pharmacy.
Most have assumed it is not for them.
That assumption is worth examining.
What specialty pharmacy actually means for an independent
Specialty pharmacy is not a single category.
It is a collection of high-cost, high-touch medication categories where the dispensing process requires clinical complexity, patient monitoring, patient education, and coordination with prescribers that standard dispensing workflows were not built to handle.
The medication categories that define specialty pharmacy in practice include oncology supportive care, HIV and infectious disease, hepatitis C, multiple sclerosis, rheumatoid arthritis and other autoimmune conditions, growth hormone therapy, and certain rare disease categories.
What these categories share is not just cost.
They share the need for a pharmacist who knows the patient, monitors adherence and side effects actively, communicates with the prescribing physician regularly, and manages the prior authorization and access program complexity that surrounds these medications.
An independent pharmacy with strong patient relationships is structurally better positioned to provide that than a mail-order specialty pharmacy or a chain specialty hub that the patient has never visited.
The question is not whether you can credential into specialty pharmacy.
The question is where to start.
Why chains do not automatically win in specialty
The assumption that specialty pharmacy belongs to the large chains and integrated health systems is understandable.
It is also incomplete.
Large specialty pharmacy operations excel at volume processing and at navigating the access programs for medications covered under commercial insurance. They are not built for the kind of ongoing, personalized clinical relationship that complex patients actually need and that prescribers increasingly recognize as essential to adherence.
A rheumatologist who has one patient with significant medication complexity does not want that patient calling a 1-800 number at a mail-order specialty pharmacy.
They want that patient talking to a pharmacist who knows them.
An independent pharmacy that has established a relationship with a rheumatology or neurology practice — and that has the clinical infrastructure to support complex medication management — is genuinely competitive for that referral.
The accreditation reality
Credentialing for specialty pharmacy requires accreditation.
The two primary accreditation bodies in the US context are URAC and the Accreditation Commission for Health Care, known as ACHC. Both offer specialty pharmacy accreditation pathways. Both require demonstrating that your pharmacy meets specific standards for patient safety, clinical services, quality management, and medication handling.
The accreditation process is real work.
It requires dedicated staff time, documented policies and procedures, quality management systems, and in some cases physical facility upgrades.
The typical timeline from beginning the accreditation process to receiving accreditation is six to twelve months.
The typical cost of the accreditation process, including consulting support, policy development, and accreditation fees, runs between $15,000 and $40,000 depending on the scope of the accreditation and the starting state of your quality systems.
That is a real investment.
It is also a one-time investment that opens access to specialty drug dispensing revenue that generates margins far above standard commercial dispensing in most markets.
Where to start without full specialty accreditation
Full specialty pharmacy accreditation is the destination for pharmacies building a significant specialty revenue component.
It is not the starting point.
The starting point is identifying one specialty medication category where your existing patient population and your existing prescriber relationships create a natural opportunity.
HIV pharmacy is one of the most accessible entry points for independent pharmacies in markets with any meaningful HIV patient population. The clinical complexity is real but manageable. The patient relationship and adherence monitoring requirements align well with what strong independent pharmacies already do. The prescriber community for HIV care tends to value the kind of ongoing pharmacist relationship that independent pharmacy can provide.
Oncology supportive care — not the chemotherapy itself, but the supportive medications that cancer patients take throughout treatment — is another accessible entry point. These medications are often commercially dispensed rather than requiring specialty hub dispensing, but the patients taking them have complex needs and benefit significantly from close pharmacist engagement.
Rheumatology is a third accessible entry point, particularly for pharmacies in markets with established rheumatology practices. The self-injectable biologics used in rheumatoid arthritis and related conditions require patient training, adherence monitoring, and prior authorization management that independent pharmacies can provide effectively.
In each case, the starting point is the same as the compounding physician relationship model.
Find the prescriber in your market who has a patient population with a recurring, specific need. Build one relationship around serving that population well. Let that relationship demonstrate your capability before you pursue accreditation.
The revenue structure
Specialty medications are expensive.
A single specialty prescription may cost anywhere from several hundred to several thousand dollars per fill.
The reimbursement model for specialty pharmacy is different from standard commercial dispensing. Gross margins on specialty medications are often lower in percentage terms than standard dispensing. What makes the economics work is the combination of dispensing revenue at higher absolute dollar amounts, clinical service fees for the monitoring and coordination activities that specialty patients require, and the adherence and outcome quality that generates repeat fills and prescriber loyalty.
A single HIV specialty pharmacy patient filling a once-monthly regimen generates meaningful monthly dispensing revenue and potentially generates additional clinical service fees for the monitoring activities your pharmacist provides.
A rheumatology patient on a quarterly injectable biologic is a different revenue profile but a similar relationship dynamic.
The specific revenue figures vary too much by medication category, payer mix, and market to quote meaningfully here. The general principle is that specialty pharmacy revenue at meaningful volume changes the financial profile of an independent pharmacy in ways that standard dispensing volume alone cannot.
What this requires of your pharmacy
Specialty pharmacy is not a service you add to a dispensing business without changing the dispensing business.
It requires clinical infrastructure. Pharmacist time for patient monitoring, prescriber communication, and adherence management. Documentation systems that support the clinical service billing that accompanies specialty dispensing. Temperature-controlled storage for specialty medications that require refrigeration. Prior authorization management capacity.
It also requires a realistic assessment of your starting position.
The pharmacies that build successful specialty programs from an independent base are almost uniformly the ones that already have strong prescriber relationships, strong patient relationship depth, and an existing culture of clinical service delivery rather than purely dispensing throughput.
If those things are not yet present, building them is the prerequisite, not the specialty credentialing itself.
What specialty pharmacy looks like outside the United States
In the UK, the equivalent category is homecare pharmacy — the dispensing and clinical management of high-cost medicines for patients with complex conditions outside of hospital settings. The NHS homecare market is significant and growing, and a subset of community pharmacies have built meaningful revenue through homecare dispensing contracts.
In Canada, specialty pharmacy is a growing category with significant provincial variation in how high-cost drugs are reimbursed and which pharmacy types can dispense them.
In Nigeria and across Sub-Saharan Africa, the specialty pharmacy equivalent is the management of HIV antiretroviral therapy, which represents one of the largest pharmaceutical categories by patient volume in many markets. Independent pharmacies that have built strong ARV dispensing and adherence support programs are providing a service with genuine population health impact and increasingly formal recognition in the regulatory and funding environment.
In Australia, the Pharmaceutical Benefits Scheme includes provisions for complex drug programs that create specialty-adjacent opportunities for community pharmacies with appropriate clinical capacity.
The question to answer before pursuing this
Do you have a prescriber relationship — or can you develop one — where a specific complex patient population would benefit from the kind of clinical pharmacy engagement that specialty pharmacy requires?
If yes, the next step is a conversation with that prescriber about what their patients currently experience when they try to access and stay on their specialty medications.
That conversation will tell you more about whether the opportunity is real in your market than any accreditation checklist.
Read next on Blinkerhub:
The physician relationship framework that underpins the specialty pharmacy entry strategy is covered in detail in our compounding revenue article — the commercial logic is identical even though the medication categories are different.
If specialty pharmacy credentialing connects to a larger question about where your independent pharmacy business is going over the next five years, the viability analysis covers the strategic context for that decision.
And if you have not yet built the financial clarity at the plan level that a major investment decision like specialty credentialing requires, the reimbursement audit is the right starting point.
Blinkerhub is a free weekly intelligence newsletter for independent pharmacy owners worldwide. Not affiliated with any PBM, chain pharmacy, trade association, or pharmacy software vendor. Published every Tuesday at pharmacy.blinkerhub.com.
Specialty pharmacy accreditation requirements, reimbursement structures, and regulatory frameworks vary by state and change over time. Consult URAC, ACHC, and your state board of pharmacy for current requirements.